Combined effects of probiotic and chondroprotector during osteoarthritis in rats.


Journal

Panminerva medica
ISSN: 1827-1898
Titre abrégé: Panminerva Med
Pays: Italy
ID NLM: 0421110

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 21 3 2020
medline: 7 4 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

Osteoarthritis (OA) is a joint affection, defined by articular cartilage demolition, risks of which rise with age. The aim of this study was to compare the efficacy of chondroitin sulfate (CS) course and multistrain live probiotic (LP) administered alone or in combination on the expression of TLR-2, TLR-4, TNF-α and NF-κB in articular cartilage, subchondral bone and synovial membrane during OA in rats. OA was induced in male rats by injecting monoiodoacetate (MIA) in right hind knee. Therapeutic groups received 3 mg/kg of chondroprotector (ChP) CS for 28 days and/or 140 mg/kg of LP diet for 14 days. The expression of TLR-2, TLR-4, TNF-α and NF-κB in articular cartilage, subchondral bone and synovial membrane were determined with immunohistochemical staining kits (Thermo Fisher Scientific). It was established that MIA injection is associated with long-term structural changes in joint tissues that corresponded to OA-like features and associated with activation of pathogen-recognizing molecules and proinflammatory signaling pathways expression. Separate therapy with ChP and probiotics slightly decreased OA score limiting cell death and subchondral bone resorption. However, these changes were not associated with a significant decrease in TLR-2, TLR-4, NF-kB and TNF-α expression. On the other hand, the combination of ChP and LP treatment significantly decreased OA score. This correlated with a decrease in TLR-2, TLR-4, NF-kB and TNF-α expression in chondrocytes and synovial cells. The outcomes of our research prove that ChPs amplify the positive action of LPs in OA attenuation.

Sections du résumé

BACKGROUND BACKGROUND
Osteoarthritis (OA) is a joint affection, defined by articular cartilage demolition, risks of which rise with age. The aim of this study was to compare the efficacy of chondroitin sulfate (CS) course and multistrain live probiotic (LP) administered alone or in combination on the expression of TLR-2, TLR-4, TNF-α and NF-κB in articular cartilage, subchondral bone and synovial membrane during OA in rats.
METHODS METHODS
OA was induced in male rats by injecting monoiodoacetate (MIA) in right hind knee. Therapeutic groups received 3 mg/kg of chondroprotector (ChP) CS for 28 days and/or 140 mg/kg of LP diet for 14 days. The expression of TLR-2, TLR-4, TNF-α and NF-κB in articular cartilage, subchondral bone and synovial membrane were determined with immunohistochemical staining kits (Thermo Fisher Scientific).
RESULTS RESULTS
It was established that MIA injection is associated with long-term structural changes in joint tissues that corresponded to OA-like features and associated with activation of pathogen-recognizing molecules and proinflammatory signaling pathways expression. Separate therapy with ChP and probiotics slightly decreased OA score limiting cell death and subchondral bone resorption. However, these changes were not associated with a significant decrease in TLR-2, TLR-4, NF-kB and TNF-α expression. On the other hand, the combination of ChP and LP treatment significantly decreased OA score. This correlated with a decrease in TLR-2, TLR-4, NF-kB and TNF-α expression in chondrocytes and synovial cells.
CONCLUSIONS CONCLUSIONS
The outcomes of our research prove that ChPs amplify the positive action of LPs in OA attenuation.

Identifiants

pubmed: 32192320
pii: S0031-0808.20.03841-0
doi: 10.23736/S0031-0808.20.03841-0
doi:

Substances chimiques

NF-kappa B 0
Tlr2 protein, rat 0
Tlr4 protein, rat 0
Toll-Like Receptor 2 0
Toll-Like Receptor 4 0
Tumor Necrosis Factor-alpha 0
Chondroitin Sulfates 9007-28-7

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-101

Auteurs

Oleksandr Korotkyi (O)

Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.

Kateryna Dvorshchenko (K)

Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.

Tetyana Falalyeyeva (T)

Taras Shevchenko National University of Kyiv, Kyiv, Ukraine - tfalalyeyeva@gmail.com.

Oksana Sulaieva (O)

Laboratory of Pathology, CSD Health Care, Kyiv, Ukraine.

Nazarii Kobyliak (N)

Department of Endocrinology, Bogomolets National Medical University, Kyiv, Ukraine.

Ludovico Abenavoli (L)

Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.

Sharmila Fagoonee (S)

Institute of Biostructures and Bioimaging, Molecular Biotechnology Center, National Research Council (CNR), Turin, Italy.

Rinaldo Pellicano (R)

Unit of Gastroenterology, Molinette Hospital, Turin, Italy.

Liudmila Ostapchenko (L)

Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH